We present an electronic nose that detects ovarian cancer based on gas emissions from blood plasma. There is currently no test available for screening or diagnostic testing of this disease, which is therefore often detected at aa late stage, resulting in a poor prognosis. Our approach correctly detected 85 out of 87 ovarian cancers, ranging from borderline to stage IV.
No takes yet. Share an insight, caveat, or question.
Eriksson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: